Literature DB >> 22322941

Sickle cell disease subphenotypes in patients from Southwestern Province of Saudi Arabia.

Abdulrahman Alsultan1, Aamer Aleem, Hazem Ghabbour, Farjah H AlGahtani, Ali Al-Shehri, Mohamed Elfaki Osman, Kadijah Kurban, Mohammed S Alsultan, Hasan Bahakim, AbdelKareem M Al-Momen.   

Abstract

Sickle cell disease (SCD) is common in the Eastern and Southwestern (SW) Provinces of Saudi Arabia. We studied 159 patients with SCD to better characterize its phenotype in the SW Province, where patients usually have a HBB haplotype of African origin. All cases had history and examination, chart review, and laboratory testing. Blood tests were obtained during steady state and included: complete blood count, reticulocytes, hemoglobin electrophoresis, lactate dehydrogenase, and G6PD level. HBB haplotype and presence of α-thalassemia were also determined. Frequency of various SCD complications was as follows: painful episodes of variable severity occurred in majority of patients (98%), osteonecrosis (14%), acute chest syndrome (22%), splenic sequestration (23%), gallstones (34%), stroke (7.5%), priapism (2.6%), serious infections (11.5%), and persistent splenomegaly (11%) beyond 5 years of age. No patient had leg ulcer. History of asthma and high steady state white blood cells count were associated with increased risk of acute chest syndrome. Coinheritance of α-thalassemia was associated with a lower frequency of gallstones. Higher fetal hemoglobin level was associated with persistent splenomegaly but not with other complications. Splenic sequestration was more common among males and was associated with lower steady state hemoglobin. SCD phenotype in the SW Province is variable and comparable with African Americans except for the rarity of priapism and the absence of leg ulcers. Fetal hemoglobin level was not associated with SCD vaso-occlusive complications. New genetic modifiers and environmental factors might modulate the phenotype of SCD in Saudi Arabia.

Entities:  

Mesh:

Year:  2012        PMID: 22322941     DOI: 10.1097/MPH.0b013e3182422844

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  13 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 2.  Beta-globin gene haplotypes among cameroonians and review of the global distribution: is there a case for a single sickle mutation origin in Africa?

Authors:  Valentina J Ngo Bitoungui; Gift D Pule; Neil Hanchard; Jeanne Ngogang; Ambroise Wonkam
Journal:  OMICS       Date:  2015-03

3.  Contribution of Reduced Interleukin-10 Levels to the Pathogenesis of Osteomyelitis in Children with Sickle Cell Disease.

Authors:  Sameh Sarray; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2015-07-01

4.  Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1?

Authors:  Suellen Rodrigues Martins; Sílvia Letícia de Oliveira Toledo; Aislander Junio da Silva; Fernanda Santos Mendes; Marina Mendes de Oliveira; Leticia Gonçalves Resende Ferreira; Luci Maria Sant'Ana Dusse; Maria das Graças Carvalho; Danyelle Romana Alves Rios; Patrícia Nessralla Alpoim; Melina de Barros Pinheiro
Journal:  Ann Hematol       Date:  2021-10-19       Impact factor: 3.673

5.  Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia.

Authors:  Pallav Bhatnagar; Jeffrey R Keefer; James F Casella; Emily A Barron-Casella; Christopher J Bean; Craig W Hooper; Amanda B Payne; Dan E Arking; Michael R Debaun
Journal:  Pediatr Blood Cancer       Date:  2013-05-15       Impact factor: 3.167

Review 6.  Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Authors:  Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Paediatr Respir Rev       Date:  2013-11-15       Impact factor: 2.726

7.  Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.

Authors:  Abdulrahman Alsultan; Mohammed K Alabdulaali; Paula J Griffin; Ahmed M Alsuliman; Hazem A Ghabbour; Paola Sebastiani; Waleed H Albuali; Amein K Al-Ali; David H K Chui; Martin H Steinberg
Journal:  Br J Haematol       Date:  2013-11-13       Impact factor: 6.998

Review 8.  A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.

Authors:  Gift D Pule; Shaheen Mowla; Nicolas Novitzky; Charles S Wiysonge; Ambroise Wonkam
Journal:  Expert Rev Hematol       Date:  2015-09-01       Impact factor: 2.819

Review 9.  Prevalence of Stroke in Asian Patients with Sickle Cell Anemia: A Systematic Review and Meta-Analysis.

Authors:  Sandip Kuikel; Robin Rauniyar; Sanjeev Kharel; Anil Bist; Subarna Giri; Sahil Thapaliya; Sunanda Paudel
Journal:  Neurol Res Int       Date:  2021-06-03

10.  The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival.

Authors:  Maryam Bibi Rumaney; Valentina Josiane Ngo Bitoungui; Anna Alvera Vorster; Raj Ramesar; Andre Pascal Kengne; Jeanne Ngogang; Ambroise Wonkam
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.